However, other reports demonstrating losses of expression of nuclear YAP in various cancers, including HNSCC [116], breast cancer [118, 119], haematological cancers [120], and CRC [121], demonstrate that contradictory reports exist on the expression of YAP in cancers including CRC. Here, YAP1 is linked to breast carcinoma.